Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- 29 Acute bronchitis and acute exacerbations of chronic airways disease
- 30 Croup, supraglottitis, and laryngitis
- 31 Atypical pneumonia
- 32 Community-acquired pneumonia
- 33 Nosocomial pneumonia
- 34 Aspiration pneumonia
- 35 Lung abscess
- 36 Empyema and bronchopleural fistula
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
32 - Community-acquired pneumonia
from Part V - Clinical syndromes: respiratory tract
Published online by Cambridge University Press: 05 April 2015
Edited by
Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- 29 Acute bronchitis and acute exacerbations of chronic airways disease
- 30 Croup, supraglottitis, and laryngitis
- 31 Atypical pneumonia
- 32 Community-acquired pneumonia
- 33 Nosocomial pneumonia
- 34 Aspiration pneumonia
- 35 Lung abscess
- 36 Empyema and bronchopleural fistula
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 214 - 220Publisher: Cambridge University PressPrint publication year: 2015
References
. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011:52(Suppl 4):S296–S304.CrossRefGoogle ScholarPubMed
, , , et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest. 1992;101:1005–1012.CrossRefGoogle ScholarPubMed
, , , et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250.CrossRefGoogle ScholarPubMed
, , , et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–382.CrossRefGoogle ScholarPubMed
, , , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–S72.CrossRefGoogle Scholar
, . Determining the duration of therapy for patients with community-acquired pneumonia. Curr Infect Dis Rep. 2013;15:191–195.CrossRefGoogle ScholarPubMed
, , , et al. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Current Opin Infect Dis. 2013;26:159–167.CrossRefGoogle ScholarPubMed
, , , et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011;17(Suppl 6):E1–E59.CrossRefGoogle ScholarPubMed